Bio-Path (NASDAQ:BPTH) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Monday. The firm issued a sell rating on the stock. Separately, Roth Mkm reiterated a buy rating and issued a $20.00 target price on shares of Bio-Path in a research note on Monday, July 8th. Get Our Latest Research […]
10 Oct 02:40 · The Cerbat Gem